sorafenib has been researched along with fulvestrant in 4 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (fulvestrant) | Trials (fulvestrant) | Recent Studies (post-2010) (fulvestrant) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 2,712 | 207 | 1,196 |
| Protein | Taxonomy | sorafenib (IC50) | fulvestrant (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0061 | |
| Estrogen receptor | Rattus norvegicus (Norway rat) | 0.0059 | |
| Progesterone receptor | Homo sapiens (human) | 0.0002 | |
| Steroid hormone receptor ERR1 | Homo sapiens (human) | 0.002 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 0.006 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0104 | |
| Bile acid receptor | Homo sapiens (human) | 0.79 | |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brown, RE; Buryanek, J; Pfister, S; Rytting, ME; Vats, TS; Wolff, JE | 1 |
| Agard, DA; Duan, D; Elnatan, D; Logie, J; McLaughlin, CK; Shoichet, BK; Shoichet, MS; Torosyan, H | 1 |
| Du, X; Jacobson, MP; Lak, P; O'Donnell, H; Shoichet, BK | 1 |
1 review(s) available for sorafenib and fulvestrant
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for sorafenib and fulvestrant
| Article | Year |
|---|---|
Preliminary experience with personalized and targeted therapy for pediatric brain tumors.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Boronic Acids; Bortezomib; Brain Neoplasms; Child; Child, Preschool; Curcumin; Disease-Free Survival; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Infant; Male; Niacinamide; Phenylurea Compounds; Pyrazines; Pyridines; Sirolimus; Sorafenib; Survival Rate | 2012 |
2 other study(ies) available for sorafenib and fulvestrant
| Article | Year |
|---|---|
Internal Structure and Preferential Protein Binding of Colloidal Aggregates.
Topics: Bacterial Proteins; beta-Lactamases; Colloids; Coloring Agents; Congo Red; DNA; Dynamic Light Scattering; Estradiol; Fluoresceins; Fulvestrant; Niacinamide; Peptides; Phenylurea Compounds; Protein Binding; Protein Folding; Proteins; Ribosomal Proteins; Scattering, Small Angle; Sorafenib; Trypsin; Trypsin Inhibitors; X-Ray Diffraction | 2017 |
A Crowding Barrier to Protein Inhibition in Colloidal Aggregates.
Topics: Adsorption; Bacterial Proteins; beta-Lactamases; Colloids; Enzyme Assays; Fulvestrant; Kinetics; Malate Dehydrogenase; Protein Binding; Sorafenib | 2021 |